U.S. Physical Therapy, Inc. (NYSE:USPH) Receives $105.33 Average Price Target from Brokerages

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) have received a consensus recommendation of “Moderate Buy” from the seven brokerages that are currently covering the company, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $105.3333.

USPH has been the subject of several analyst reports. Citigroup reissued a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Monday, December 15th. Weiss Ratings restated a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday. JPMorgan Chase & Co. lowered their price target on shares of U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating on the stock in a report on Monday, November 24th. Finally, Barrington Research restated an “outperform” rating and issued a $103.00 price objective on shares of U.S. Physical Therapy in a research report on Monday, January 5th.

U.S. Physical Therapy Stock Down 1.9%

Shares of U.S. Physical Therapy stock opened at $85.78 on Thursday. U.S. Physical Therapy has a 12-month low of $62.77 and a 12-month high of $93.50. The company has a market cap of $1.30 billion, a P/E ratio of 36.04, a PEG ratio of 3.53 and a beta of 1.29. The company’s fifty day simple moving average is $78.93 and its two-hundred day simple moving average is $81.04. The company has a current ratio of 1.20, a quick ratio of 1.20 and a debt-to-equity ratio of 0.30.

U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Thursday, November 6th. The company reported $0.66 EPS for the quarter, missing analysts’ consensus estimates of $0.67 by ($0.01). U.S. Physical Therapy had a return on equity of 8.62% and a net margin of 5.71%.The company had revenue of $197.13 million during the quarter, compared to analysts’ expectations of $193.98 million. During the same period in the prior year, the company posted $0.69 earnings per share. The company’s revenue was up 17.3% on a year-over-year basis. Research analysts anticipate that U.S. Physical Therapy will post 2.67 EPS for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, December 12th. Shareholders of record on Monday, November 17th were paid a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date was Monday, November 17th. U.S. Physical Therapy’s dividend payout ratio is 75.63%.

Hedge Funds Weigh In On U.S. Physical Therapy

A number of institutional investors and hedge funds have recently added to or reduced their stakes in USPH. Royal Bank of Canada boosted its stake in shares of U.S. Physical Therapy by 3.4% during the 1st quarter. Royal Bank of Canada now owns 79,238 shares of the company’s stock worth $5,733,000 after purchasing an additional 2,594 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in U.S. Physical Therapy by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,897 shares of the company’s stock worth $644,000 after buying an additional 391 shares in the last quarter. Jane Street Group LLC increased its holdings in U.S. Physical Therapy by 249.3% during the 1st quarter. Jane Street Group LLC now owns 49,309 shares of the company’s stock worth $3,568,000 after purchasing an additional 35,191 shares during the last quarter. Parallel Advisors LLC raised its holdings in U.S. Physical Therapy by 90.6% in the second quarter. Parallel Advisors LLC now owns 448 shares of the company’s stock valued at $35,000 after acquiring an additional 213 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC acquired a new position in U.S. Physical Therapy in the second quarter worth about $341,000.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.